查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1936984

全球臨床試驗用品市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Clinical Trial Supplies Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 166 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

臨床試驗用品市場規模預計將從 2025 年的 35.2 億美元成長到 2034 年的 65.6 億美元，2026 年至 2034 年的複合年成長率為 7.14%。

由於臨床試驗數量的增加以及製藥和生物技術行業對高效供應鏈管理的需求日益成長，臨床試驗用品市場預計將迎來顯著成長。隨著臨床試驗變得日益複雜，可靠及時地供應臨床實驗用產品（包括藥物、醫療設備和生物材料）變得至關重要。全球為加速藥物研發進程所做的努力，尤其是在新冠疫情之後，凸顯了穩健的臨床試驗供應策略的重要性。隨著各機構尋求最佳化臨床試驗營運並提高患者招募和留存率，這一趨勢預計將推動市場成長。

物流和供應鏈管理領域的創新正在重塑臨床試驗供應市場的未來模式。即時追蹤系統、溫控運輸解決方案和自動化庫存管理等先進技術的整合，正在提升供應鏈的效率和透明度。這些創新使申辦方和受託研究機構(CRO) 能夠即時監控臨床試驗用品的狀態，確保臨床實驗用藥品以適宜的狀態按時送達試驗中心。此外，分散式臨床試驗的興起正在改變市場格局，隨著遠端監測和遠端醫療解決方案的日益普及，靈活且適應性強的供應鏈策略也變得至關重要。

此外，臨床試驗用品市場將受益於監管審查的加強和供應鏈管理最佳實踐的建立。隨著監管機構強調臨床試驗品質和合規性的重要性，各機構將面臨壓力，需要實施嚴格的品管措施並投資於值得信賴的供應鏈合作夥伴。製藥公司、合約研究機構 (CRO) 和物流供應商之間的合作對於推動臨床試驗用品供應策略和試驗的成功執行至關重要。隨著市場的發展，重點將轉向將臨床試驗用品整合到更廣泛的臨床開發框架中，從而凸顯高效的供應鏈管理對於及時、成功地獲得試驗結果的重要性。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球臨床試驗用品市場（依臨床階段分類）

  • 市場分析、洞察與預測
  • 第一階段
  • 第二階段
  • 第三階段
  • 其他

5. 全球臨床試驗用品市場（按產品和服務分類）

  • 市場分析、洞察與預測
  • 製造業
  • 倉儲/配送
  • 供應鏈管理

6. 全球臨床試驗用品市場（依最終用途分類）

  • 市場分析、洞察與預測
  • 製藥
  • 生物製藥
  • 醫療設備
  • 其他

7. 全球臨床試驗用品市場（依治療用途分類）

  • 市場分析、洞察與預測
  • 腫瘤學
  • 中樞神經系統
  • 循環系統
  • 感染疾病
  • 代謝性疾病
  • 其他

8. 全球臨床試驗用品市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Almac Group
    • Biocair
    • Catalent Inc
    • KLIFO
    • Movianto
    • PCI Pharma Services
    • Sharp Services LLC
    • Thermo Fischer Scientific Inc
    • Marken
    • PAREXEL International Corporation
簡介目錄
Product Code: VMR11214170

The Clinical Trial Supplies Market size is expected to reach USD 6.56 Billion in 2034 from USD 3.52 Billion (2025) growing at a CAGR of 7.14% during 2026-2034.

The clinical trial supplies market is poised for significant growth, driven by the increasing number of clinical trials and the rising demand for efficient supply chain management in the pharmaceutical and biotechnology sectors. As the complexity of clinical trials escalates, the need for reliable and timely delivery of investigational products, including drugs, devices, and biological materials, becomes paramount. The global focus on accelerating drug development processes, particularly in the wake of the COVID-19 pandemic, has underscored the importance of robust clinical trial supply strategies. This trend is expected to propel the market forward, as organizations seek to optimize their clinical trial operations and enhance patient recruitment and retention.

Innovations in logistics and supply chain management are shaping the future of the clinical trial supplies market. The integration of advanced technologies, such as real-time tracking systems, temperature-controlled shipping solutions, and automated inventory management, is improving the efficiency and transparency of supply chains. These innovations enable sponsors and contract research organizations (CROs) to monitor the status of clinical trial supplies in real-time, ensuring that investigational products are delivered to sites on time and in optimal condition. Additionally, the rise of decentralized clinical trials is transforming the landscape, as remote monitoring and telehealth solutions become more prevalent, necessitating flexible and adaptive supply chain strategies.

Moreover, the clinical trial supplies market will benefit from increased regulatory scrutiny and the establishment of best practices in supply chain management. As regulatory bodies emphasize the importance of quality and compliance in clinical trials, organizations will be compelled to adopt stringent quality control measures and invest in reliable supply chain partners. Collaborative efforts between pharmaceutical companies, CROs, and logistics providers will be essential in advancing clinical trial supply strategies and ensuring the successful execution of trials. As the market evolves, the focus will shift towards integrating clinical trial supplies into broader clinical development frameworks, emphasizing the importance of efficient supply chain management in achieving timely and successful trial outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Clinical Phase

  • Phase I
  • Phase II
  • Phase III
  • Other

By Product & Services

  • Manufacturing
  • Storage & Distribution
  • Supply chain management

By End-use

  • Pharmaceutical
  • Biologics
  • Medical device
  • Others

By Therapeutic Use

  • Oncology
  • CNS
  • Cardiovascular
  • Infectious disease
  • Metabolic disorders
  • Others

COMPANIES PROFILED

  • Almac Group, Biocair, Catalent Inc, KLIFO, Movianto, PCI Pharma Services, Sharp Services LLC, Thermo Fischer Scientific Inc, Marken, PAREXEL International Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Clinical Phase
  • 4.2. Phase I Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Phase II Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Phase III Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product & Services
  • 5.2. Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Storage & Distribution Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Supply chain management Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Pharmaceutical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Biologics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Medical device Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Therapeutic Use
  • 7.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. CNS Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Cardiovascular Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Infectious disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Metabolic disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Clinical Phase
    • 8.2.2 By Product & Services
    • 8.2.3 By End-use
    • 8.2.4 By Therapeutic Use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Clinical Phase
    • 8.3.2 By Product & Services
    • 8.3.3 By End-use
    • 8.3.4 By Therapeutic Use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Clinical Phase
    • 8.4.2 By Product & Services
    • 8.4.3 By End-use
    • 8.4.4 By Therapeutic Use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Clinical Phase
    • 8.5.2 By Product & Services
    • 8.5.3 By End-use
    • 8.5.4 By Therapeutic Use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Clinical Phase
    • 8.6.2 By Product & Services
    • 8.6.3 By End-use
    • 8.6.4 By Therapeutic Use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CLINICAL TRIAL SUPPLIES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Almac Group
    • 10.2.2 Biocair
    • 10.2.3 Catalent Inc
    • 10.2.4 KLIFO
    • 10.2.5 Movianto
    • 10.2.6 PCI Pharma Services
    • 10.2.7 Sharp Services LLC
    • 10.2.8 Thermo Fischer Scientific Inc
    • 10.2.9 Marken
    • 10.2.10 PAREXEL International Corporation